thiazolyl blue has been researched along with soblidotin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukumoto, H; Kobayashi, M; Koh, Y; Nakamura, T; Natsume, T; Nishio, K; Ohe, Y; Saijo, N; Takahashi, F | 1 |
| Kobayashi, M; Natsume, T; Watanabe, J | 1 |
2 other study(ies) available for thiazolyl blue and soblidotin
| Article | Year |
|---|---|
Enhanced antitumor activities of TZT-1027 against TNF-alpha or IL-6 secreting Lewis lung carcinoma in vivo.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; DNA, Complementary; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Interleukin-6; LLC-PK1 Cells; Mice; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Oligopeptides; RNA, Neoplasm; Tetrazolium Salts; Thiazoles; Transfection; Tumor Necrosis Factor-alpha | 2002 |
Comparison of the antivascular and cytotoxic activities of TZT-1027 (Soblidotin) with those of other anticancer agents.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Membrane Permeability; Cell Survival; Colonic Neoplasms; Dextrans; Diffusion; Endothelial Cells; Endothelium, Vascular; Female; Fluorescein-5-isothiocyanate; Humans; Indicators and Reagents; Mice; Mice, Inbred BALB C; Oligopeptides; Tetrazolium Salts; Thiazoles; Umbilical Veins | 2007 |